Evidence map›Paper›PMID 19214219›Full record

ArticlePLoS pathogens2009

Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization.

Sharon Lederer, David Favre, Kathie-Anne Walters, Sean Proll, Bittoo Kanwar, Zeljka Kasakow, Carole R Baskin, Robert Palermo, Joseph M McCune, Michael G Katze

Abstract read
In one paragraph

Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sharon LedererDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.
David Favre
Kathie-Anne Walters
Sean Proll
Bittoo Kanwar
Zeljka Kasakow
Carole R Baskin
Robert Palermo
Joseph M McCune
Michael G Katze

Funding

YILMA SIV VACCINIA VACCINE TRIALP51RR000166 · NCRR · UNIVERSITY OF WASHINGTON · PI HU, SHIU-LOK · 1985 to 2011
$161.1M
ZONA PELLUCIDA PEPTIDES AS IMMUNOCONTRACEPTIVE ANTIGENSP51RR000169 · NCRR · UNIVERSITY OF CALIFORNIA DAVIS · PI HYDE, DALLAS MELVIN · 1985 to 2011
$126.2M
PROTEOMICS COREP30DA015625 · NIDA · UNIVERSITY OF WASHINGTON · PI KATZE, MICHAEL G · 2002 to 2012
$18.9M
DEVELOPMENT OF A PRIMATE GENOMICS RESOURCER24RR016354 · NCRR · UNIVERSITY OF WASHINGTON · PI KATZE, MICHAEL G · 2002 to 2011
$9.7M
Supplement to Mechanisms of Protection in Live-attenuated AIDS VaccinesP01AI066314 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MILLER, CHRISTOPHER JAMES · 2005 to 2009
$8.5M
TRAINING PROGRAM IN PEDIATRIC GASTROENTEROLOGY/NUTRITIONT32DK007762 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI James Bayrer · 1998 to 2026
$7.3M
NIH Director's Pioneer Award (RMI)DP1OD000329 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2004 to 2008
$4.2M
PROTECTIVE MECHANISMS WITH ATTENUATED LENTIVIRAL VACCINER01AI044480 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI MILLER, CHRISTOPHER · 1998 to 2002
$2.5M
Studies in Children with Digestive DisordersK24DK060617 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HEYMAN, MELVIN B. · 2002 to 2011
$1.6M
NCRR NIH HHS P51 RR000166NCRR NIH HHS P51RR000166NCRR NIH HHS P51 RR000169NCRR NIH HHS R24 RR016354NCRR NIH HHS R24RR016354NCRR NIH HHS U51RR00169NIAID NIH HHS N01 AI030018NIAID NIH HHS P01 AI066314NIAID NIH HHS R01 AI44480NIDA NIH HHS P30 DA015625NIDA NIH HHS P30DA015625NIDDK NIH HHS K24 DK060617NIDDK NIH HHS T32 DK007762NIH HHS DP1 OD000329NIH HHS DPI OD00329
6 · The paper itself

Abstract

Simian immunodeficiency virus (SIV) infection leads to AIDS in experimentally infected macaques, whereas natural reservoir hosts exhibit limited disease and pathology. It is, however, unclear how natural hosts can sustain high viral loads, comparable to those observed in the pathogenic model, without developing severe disease. We performed transcriptional profiling on lymph node, blood, and colon samples from African green monkeys (natural host model) and Asian pigtailed macaques (pathogenic model) to directly compare gene expression patterns during acute pathogenic versus non-pathogenic SIV infection. The majority of gene expression changes that were unique to either model were detected in the lymph nodes at the time of peak viral load. Results suggest a shift toward cellular stress pathways and Th1 profiles during pathogenic infection, with strong and sustained type I and II interferon responses. In contrast, a strong type I interferon response was initially induced during non-pathogenic infection but resolved after peak viral load. The natural host also exhibited controlled Th1 profiles and better preservation of overall cell homeostasis. This study identified gene expression patterns that are specific to disease susceptibility, tissue compartmentalization, and infection duration. These patterns provide a unique view of how host responses differ depending upon lentiviral infection outcome.

Indexed as

Analysis of VarianceAnimalsApoptosisChlorocebus aethiopsCluster AnalysisColonDisease ProgressionDisease SusceptibilityGene ExpressionInflammationInterferon-gammaInterferon Type ILymph NodesMacaca nemestrinaMaleNF-kappa BInterferon-gammaInterferon Type INF-kappa B

Identifiers

PMID19214219
PMCPMC2633618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.